Developer-owner Aralon Properties has leased a speculative 142,000-square-foot office and R&D building in South San Francisco to a rapidly expanding biotech company, the San Francisco Business Times has reported. The development benefited from a $55 million construction loan funded by First Republic Bank, originated in early 2021, according to CommercialEdge data.
InterVenn Biosciences is taking the space at 499 Forbes Blvd. under a 10-year lease, for which Kidder Mathews Senior Vice President Joe Cammarata and Executive Vice President Gregg Domanico represented the landlord.
For the full story, go to Commercial Property Executive.
© 2022 Commercial Property Executive. All rights reserved.
